Delcath stock split
Dec 19, 2019 · NEW YORK, Dec. 19, 2019 (GLOBE NEWSWIRE) -- Delcath Systems, Inc. (OTCQB: DCTH), an interventional oncology company focused on the treatment of primary and metastatic liver cancers, announced that the Company’s Board of Directors has authorized a 1-for-700 reverse stock split of the Company’s common stock. OTC Markets | DCTH Jul 01, 2019 · As previously announced, we recently completed the listing process for our common stock on the OTCQB Market. As a consequence of shareholder non-approval of our proposed reverse stock split earlier this month, Delcath could not regain compliance with the continued listing requirements on the Nasdaq Capital Market. Should I buy Delcath Systems, Inc. (DCTH) - Zacks Should I buy Delcath Systems, Inc. (DCTH)? Use the Zacks Rank and Style Scores to find out is DCTH is right for your portfolio.
Delcath Systems Announces 1-for-700 Reverse Stock Split to ...
About DCTH - Stock Split History DCTH (DCTH) has 2 splits in our DCTH stock split history database. The first split for DCTH took place on April 09, 2014. This was a 1 for 16 reverse split, meaning for each 16 shares of DCTH owned pre-split, the shareholder now owned 1 share. Investors - Delcath Systems Inc. [2019-12-19] Delcath Systems Announces 1-for-700 Reverse Stock Split to be Effective on December 24, 2019 [2019-12-03] Delcath Systems to Present at the 12th Annual LD Micro Main Event on December 10, 2019 [2019-10-22] Delcath Systems Announces Postponement of Reverse Stock Split
Delcath Systems Announces Ratio for Reverse Stock Split ...
DCTH Stock Price | Delcath Systems Inc. Stock Quote (U.S ... Delcath inks deal with convertible debt holders for short-term operating capital, reverse stock split to proceed Sep. 22, 2017 at 9:04 a.m. ET on Seeking Alpha Delcath Systems Announces 1-for-700 Reverse Stock Split to ... Dec 19, 2019 · The reverse stock split will be effected prior to the initiation of trading on December 24, 2019. The reverse stock split supersedes the 1-for-100 reverse stock split previously announced on Delcath Systems Inc. (DCTH) Stock Message Board - InvestorsHub
Delcath Announces Ratio for Reverse Split Authorization ...
Delcath inks deal with convertible debt holders for short-term operating capital, reverse stock split to proceed Sep. 22, 2017 at 9:04 a.m. ET on Seeking Alpha Delcath Systems Announces 1-for-700 Reverse Stock Split to ... Dec 19, 2019 · The reverse stock split will be effected prior to the initiation of trading on December 24, 2019. The reverse stock split supersedes the 1-for-100 reverse stock split previously announced on Delcath Systems Inc. (DCTH) Stock Message Board - InvestorsHub About Delcath Systems (OTCQB:DCTH) Delcath Systems, Inc. is a specialty pharmaceutical and medical device company focused on oncology. Their proprietary product-Melphalan Hydrochloride for Injection for use with the Delcath Hepatic Delivery System (Melphalan/HDS)-is designed to administer high dose chemotherapy to the liver, while controlling the systemic exposure to those agents. About DCTH - Stock Split History
Investors - Delcath Systems Inc.
Oct 22, 2019 · Delcath Systems, Inc. is an interventional oncology company focused on the treatment of primary and metastatic liver cancers. Our investigational …
The first split for DCTH took place on April 09, 2014. This was a 1 for 16 reverse split, meaning for each 16 shares of DCTH owned pre-split, the shareholder now